BriaCell Therapeutics Corp.(BCTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BCTX BriaCell Therapeutics Corp.

Pre-Market Trading 01-10 06:00:59 EST

0.4319

-0.0151

-3.38%

盘前0.4127

-0.0192-4.45%

04:55 EST

High0.4470	Low0.4130	Vol996.04K
Open0.4470	D1 Closing0.4470	Amplitude7.61%
Mkt Cap19.09M	Tradable Cap17.52M	Total Shares44.20M
T/O422.22K	T/O Rate2.46%	Tradable Shares40.57M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"BCTX","market":"US","secType":"STK","nameCN":"BriaCell Therapeutics Corp.","latestPrice":0.4319,"timestamp":1736370000000,"preClose":0.447,"halted":0,"volume":996042,"hourTrading":{"tag":"盘前","latestPrice":0.4127,"preClose":0.4319,"latestTime":"04:55 EST","volume":400,"amount":165.06,"timestamp":1736502902155},"delay":0,"floatShares":40565900,"shares":44204161,"eps":-0.867959,"marketStatus":"Pre-Market Trading","change":-0.0151,"latestTime":"01-10 06:00:59 EST","open":0.447,"high":0.447,"low":0.413,"amount":422220.5105286,"amplitude":0.076063,"askPrice":0.44,"askSize":100,"bidPrice":0.3777,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.867959,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1736519400000},"marketStatusCode":1,"adr":0,"listingDate":1614142800000,"exchange":"NASDAQ","adjPreClose":0.4319,"preHourTrading":{"tag":"盘前","latestPrice":0.4127,"preClose":0.4319,"latestTime":"04:55 EST","volume":400,"amount":165.06,"timestamp":1736502902155},"postHourTrading":{"tag":"盘后","latestPrice":0.4299,"preClose":0.4319,"latestTime":"19:51 EST","volume":26205,"amount":11189.740105,"timestamp":1736383906569},"volumeRatio":0.573777988456241,"impliedVol":1.3131,"impliedVolPercentile":0.536},"requestUrl":"/m/hq/s/BCTX/tweets","defaultTab":"tweets","newsList":[{"id":"2500270001","title":"BriaCell Plans Share Consolidation for Nasdaq Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2500270001","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500270001?lang=en_us&edition=fundamental","pubTime":"2025-01-04 06:37","pubTimestamp":1735943829,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics (TSE:BCT) has released an update. BriaCell Therapeutics announced a share consolidation plan, converting every fifteen pre-co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-plans-share-consolidation-for-nasdaq-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-plans-share-consolidation-for-nasdaq-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NDAQ","BK4588","TQQQ","BK4139","SQQQ","QLD","LU2095319765.USD","IE00BGHQF748.EUR","TSYW.SI","IE00B64PRP62.GBP","BK4112","LU2210149790.SGD","LU2210150020.SGD","NVIW.SI","NQmain","QID","USJW.SI","PSQ","IE00B3QW5Z07.USD","MNQmain","BCTX","USAW.SI",".IXIC","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2500276591","title":"BriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2500276591","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500276591?lang=en_us&edition=fundamental","pubTime":"2025-01-04 06:05","pubTimestamp":1735941900,"startTime":"0","endTime":"0","summary":"PHILADELPHIA and VANCOUVER, British Columbia, Jan. 03, 2025  -- BriaCell Therapeutics Corp.   , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, announces that the Company’s Annual General Meeting of Shareholders , which was originally scheduled to be held on Thursday, January 23, 2025, has been rescheduled. The Meeting is now scheduled to be held on Wednesday, February 5, 2025, at 9:00 a.m.  at Suite 3400, One First Canadian Place, Toronto, ON, M5X 1A4. The record date for the Meeting, December 9, 2024, is unchanged and applies to the postponed Meeting. The Meeting has been postponed due to delays stemming from the disruption in postal service in Canada, and to provide further time to solicit proxies from the Company’s shareholders.Registered shareholders are shareholders who hold their shares directly in the Company, and not through a brokerage account or depository company. Registered shareholders can call Computershare Shareholder","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/briacell-announces-rescheduling-annual-general-220500914.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ET","BCTXW","BK4561","BK4585","BCTX","BK4590","BK4139","BK4588","BK4144","BK4581"],"gpt_icon":0},{"id":"2500127656","title":"BriaCell Announces Proposed Effective Date of Share Consolidation","url":"https://stock-news.laohu8.com/highlight/detail?id=2500127656","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500127656?lang=en_us&edition=fundamental","pubTime":"2025-01-04 06:05","pubTimestamp":1735941900,"startTime":"0","endTime":"0","summary":"PHILADELPHIA and VANCOUVER, British Columbia, Jan. 03, 2025  -- BriaCell Therapeutics Corp.   , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care announced today that the Company’s board of directors has approved the consolidation  of the Company’s issued and outstanding common shares  on the basis of one  post-Consolidation Common Share for every fifteen  pre-Consolidation Common Shares. The Consolidation is being implemented to ensure that the Company continues to comply with the listing requirements of The Nasdaq Capital Market .It is anticipated that upon completion of the Consolidation, the post-Consolidation Common Shares will continue to trade on the TSX under the symbol “BCT” and on the Nasdaq under the symbol “BCTX”, under a new CUSIP number: 107930208.BriaCell is a clinical-stage biotechnology company that develops novel immunot","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/briacell-announces-proposed-effective-date-220500710.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","BK4139","QID","TSYW.SI","BCTXW","TQQQ","SQQQ","BCTX","NQmain","USAW.SI","MNQmain","NVIW.SI","QLD","PSQ","USJW.SI"],"gpt_icon":1},{"id":"2492787231","title":"Insider Purchases Worth US$5.52m See Losses As BriaCell Therapeutics Market Value Drops To CA$40m","url":"https://stock-news.laohu8.com/highlight/detail?id=2492787231","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492787231?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:05","pubTimestamp":1734613551,"startTime":"0","endTime":"0","summary":"Insiders who bought US$5.52m worth of BriaCell Therapeutics Corp.'s  stock at an average buy price of US$2.99 over the last year may be disappointed by the recent 45% decrease in the stock. This is not good as insiders invest based on expectations that their money will appreciate over time. However, as a result of recent losses, their original investment is now worth only US$1.60m.Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.BriaCell Therapeutics Insider Transactions Over The Last Year. What Might The Insider Transactions At BriaCell Therapeutics Tell Us?The recent insider purchase is heartening. We also take confidence from the longer term picture of insider transactions. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. When combined with notable insider ownership, these factors suggest BriaCell The","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insider-purchases-worth-us-5-130551585.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BCTXW","BCTX","BK4139","CA"],"gpt_icon":0},{"id":"2492189912","title":"BriaCell Adapts Meeting Procedures Amid Postal Strike","url":"https://stock-news.laohu8.com/highlight/detail?id=2492189912","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492189912?lang=en_us&edition=fundamental","pubTime":"2024-12-18 07:32","pubTimestamp":1734478346,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics (TSE:BCT) has released an update. BriaCell Therapeutics is adapting its annual general meeting procedures due to a postal str...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-adapts-meeting-procedures-amid-postal-strike?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-adapts-meeting-procedures-amid-postal-strike?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4139"],"gpt_icon":0},{"id":"2492423969","title":"Briacell Therapeutics Corp reports results for the quarter ended October 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2492423969","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492423969?lang=en_us&edition=fundamental","pubTime":"2024-12-17 23:21","pubTimestamp":1734448867,"startTime":"0","endTime":"0","summary":"Briacell Therapeutics Corp reports results for the quarter ended October 31 - Earnings SummaryBriacell Therapeutics Corp BCT.TO reported a quarterly adjusted loss of 22 cents per share for the quarter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nL8N3NI186:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTX"],"gpt_icon":0},{"id":"2492628072","title":"BriaCell Therapeutics Reports Quarterly Financial Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2492628072","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492628072?lang=en_us&edition=fundamental","pubTime":"2024-12-17 05:28","pubTimestamp":1734384507,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics ( ($TSE:BCT) ) has shared an update. BriaPro Therapeutics Corp., a subsidiary of BriaCell Therapeutics Corp., has released it...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-therapeutics-reports-quarterly-financial-loss?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-therapeutics-reports-quarterly-financial-loss?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BCTX","LENZ"],"gpt_icon":0},{"id":"2491891125","title":"BriaCell Therapeutics Closes $5.5 Million Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2491891125","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491891125?lang=en_us&edition=fundamental","pubTime":"2024-12-14 05:37","pubTimestamp":1734125836,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics (TSE:BCT) has released an update. BriaCell Therapeutics has successfully closed a $5.5 million public offering, selling 7.4 m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-therapeutics-closes-5-5-million-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-therapeutics-closes-5-5-million-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2491322908","title":"BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2491322908","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491322908?lang=en_us&edition=fundamental","pubTime":"2024-12-13 20:50","pubTimestamp":1734094200,"startTime":"0","endTime":"0","summary":"BriaCell reports influx of cancer fighting CD8+ “killer” T cell into metastatic breast cancer tumors and lymph organs turning “Cold” tumors and lymph nodes “Hot” on ImmunoPET imaging in cancer patient","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/13/2996746/0/en/BriaCell-2024-SABCS-Poster-Highlights-Ability-of-Bria-IMT-Regimen-to-Increase-Cancer-Fighting-Immune-Cells-in-Metastatic-Breast-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABIL","BCTX","NLR","CPI"],"gpt_icon":0},{"id":"2490826186","title":"BRIEF-Briacell Therapeutics Prices Public Offering Of 7.4 Mln Shares And Warrants At $0.75 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2490826186","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490826186?lang=en_us&edition=fundamental","pubTime":"2024-12-12 12:55","pubTimestamp":1733979340,"startTime":"0","endTime":"0","summary":"Dec 11  - Briacell Therapeutics Corp   :   * BRIACELL THERAPEUTICS ANNOUNCES PRICING OF $5.5 MILLION PUBLIC OFFERING   * BRIACELL THERAPEUTICS CORP - PRICES PUBLIC OFFERING OF 7.4 MILLION SHARES AND WARRANTS AT $0.75 EACHSource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","BCTX"],"gpt_icon":0},{"id":"2490260628","title":"BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2490260628","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490260628?lang=en_us&edition=fundamental","pubTime":"2024-12-12 12:54","pubTimestamp":1733979240,"startTime":"0","endTime":"0","summary":"PHILADELPHIA and Vancouver, British Columbia, Dec. 11, 2024  -- BriaCell Therapeutics Corp.   , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced the pricing of an underwritten public offering of 7,400,000 common shares and warrants to purchase 7,400,000 common shares at a combined public offering price of $0.75 per share and associated warrant. The warrants will have an exercise price of $0.9375 per share and will be immediately exercisable upon issuance for a period of five years following the date of issuance. All of the common shares and associated warrants in the offering are being offered by the Company. Total gross proceeds from the offering, before deducting underwriters discounts and other offering expenses, are expected to be approximately $5.55 million. The offering is expected to close on December 13, 2024, subject to satisfaction of customary closing conditions. The Company is relying upon the exemption set","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Fapu7tR5DxauNKta6Slkew--~B/aD0zODY7dz00NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/17b9221138faf4e9b9308828981b6076","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Fapu7tR5DxauNKta6Slkew--~B/aD0zODY7dz00NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/17b9221138faf4e9b9308828981b6076"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/briacell-therapeutics-announces-pricing-5-045400611.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BCTXW","BCTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2490132638","title":"BriaCell Therapeutics Plans Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2490132638","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490132638?lang=en_us&edition=fundamental","pubTime":"2024-12-12 05:37","pubTimestamp":1733953049,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics (TSE:BCT) has released an update. BriaCell Therapeutics has announced its plans to sell common shares and warrants in an unde...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-therapeutics-plans-public-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-therapeutics-plans-public-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BCTX"],"gpt_icon":0},{"id":"2490818237","title":"BriaCell announces common shares, warrants offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2490818237","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490818237?lang=en_us&edition=fundamental","pubTime":"2024-12-12 05:11","pubTimestamp":1733951500,"startTime":"0","endTime":"0","summary":"BriaCell (BCTX) Therapeutics announced that it intends to offer to sell common shares and warrants in an underwritten public offering. All of the c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briacell-announces-common-shares-warrants-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briacell-announces-common-shares-warrants-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BCTX"],"gpt_icon":0},{"id":"2490068026","title":"Briacell Therapeutics Corp  expected to post a loss of 8 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2490068026","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490068026?lang=en_us&edition=fundamental","pubTime":"2024-12-11 05:09","pubTimestamp":1733864945,"startTime":"0","endTime":"0","summary":"Briacell Therapeutics Corp  expected to post a loss of8cents a share - Earnings Preview Briacell Therapeutics Corp BCT.TO  is expected to show no change in quarterly revenue when it reports  results o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nL8N3NB26G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTX"],"gpt_icon":1},{"id":"2488167638","title":"BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2488167638","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488167638?lang=en_us&edition=fundamental","pubTime":"2024-12-02 20:50","pubTimestamp":1733143800,"startTime":"0","endTime":"0","summary":"The Data Safety Monitoring Board (DSMB) stated no safety concerns, and recommended continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT plus an immune check point inhibitor in metastatic breas","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/02/2989718/0/en/BriaCell-Receives-Green-Light-from-Data-Safety-Monitoring-Board-for-its-Phase-3-Study-in-Metastatic-Breast-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTX","CPI","BK4139"],"gpt_icon":0},{"id":"2486302005","title":"BriaCell Highlights Promising Breast Cancer Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2486302005","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486302005?lang=en_us&edition=fundamental","pubTime":"2024-11-26 21:48","pubTimestamp":1732628910,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics (TSE:BCT) has released an update. BriaCell Therapeutics has announced promising results from their Phase 2 clinical trial, sh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-highlights-promising-breast-cancer-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-highlights-promising-breast-cancer-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BCTX"],"gpt_icon":0},{"id":"2486077856","title":"BriaCell to highlight OS, clinical benefit data of Bria-IMT in MBC patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2486077856","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486077856?lang=en_us&edition=fundamental","pubTime":"2024-11-26 20:55","pubTimestamp":1732625708,"startTime":"0","endTime":"0","summary":"BriaCell (BCTX) Therapeutics will be highlighting its overall survival and clinical benefit data in metastatic breast cancer patients including tho...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briacell-to-highlight-os-clinical-benefit-data-of-bria-imt-in-mbc-patients?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briacell-to-highlight-os-clinical-benefit-data-of-bria-imt-in-mbc-patients?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4139","BK4086","MBC"],"gpt_icon":0},{"id":"2486077540","title":"BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2486077540","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486077540?lang=en_us&edition=fundamental","pubTime":"2024-11-26 20:50","pubTimestamp":1732625400,"startTime":"0","endTime":"0","summary":"SABCS “Spotlight” poster to be presented on Wednesday, December 11, 2024 7:00 AM – 8:30 AM CST highlights positive BriaCell survival and clinical benefit data across all metastatic breast cancer patient subtypes. Median overall survival of 13.4 months exceeds historical controls. Phase 2 final median overall survival calculation is pending, as many patients remain alive. Five poster presentations to feature increased presence of cancer fighting CD8+ “killer” T cell in metastatic breast cancer tumors, response in central nervous system  metastases and additional Bria-IMT clinical data from the Phase 2 trial of Bria-IMT + immune check point inhibitor in metastatic breast cancer. Collaboration with the Medical College of Wisconsin will investigate use of Bria-IMT + CPI in any cancer patient with central nervous system  metastases","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Fapu7tR5DxauNKta6Slkew--~B/aD0zODY7dz00NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/17b9221138faf4e9b9308828981b6076","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Fapu7tR5DxauNKta6Slkew--~B/aD0zODY7dz00NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/17b9221138faf4e9b9308828981b6076"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/briacell-2024-sabcs-spotlight-poster-125000786.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CNS","BK4097","DTH","BCTXW","CPI","BK4086","OS","MBC","BK4139","BK4135","BCTX"],"gpt_icon":0},{"id":"2486862260","title":"BriaCell director Marc Lustig resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2486862260","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486862260?lang=en_us&edition=fundamental","pubTime":"2024-11-25 20:55","pubTimestamp":1732539313,"startTime":"0","endTime":"0","summary":"BriaCell (BCTX) Therapeutics announces that it has accepted the resignation of Mr. Marc Lustig, MSc, MBA from the Board of Directors. Published fir...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briacell-director-marc-lustig-resigns?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briacell-director-marc-lustig-resigns?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BCTX"],"gpt_icon":0},{"id":"2486086954","title":"BriaCell Provides Update to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2486086954","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486086954?lang=en_us&edition=fundamental","pubTime":"2024-11-25 20:50","pubTimestamp":1732539000,"startTime":"0","endTime":"0","summary":"PHILADELPHIA, Pa. and VANCOUVER, British Columbia, Nov.  25, 2024  (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biot","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/25/2986614/0/en/BriaCell-Provides-Update-to-its-Board-of-Directors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://briacell.com","stockEarnings":[{"period":"1week","weight":-0.2356},{"period":"1month","weight":-0.6371},{"period":"3month","weight":-0.5724},{"period":"6month","weight":-0.5116},{"period":"1year","weight":-0.9108},{"period":"ytd","weight":-0.2356}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0251},{"period":"3month","weight":0.0232},{"period":"6month","weight":0.0527},{"period":"1year","weight":0.244},{"period":"ytd","weight":0.0058}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.014086},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.002131},{"month":3,"riseRate":0.75,"avgChangeRate":0.085777},{"month":4,"riseRate":0,"avgChangeRate":-0.150063},{"month":5,"riseRate":0,"avgChangeRate":-0.204537},{"month":6,"riseRate":0.75,"avgChangeRate":0.134713},{"month":7,"riseRate":0.5,"avgChangeRate":-0.054561},{"month":8,"riseRate":1,"avgChangeRate":0.163345},{"month":9,"riseRate":0.5,"avgChangeRate":0.089973},{"month":10,"riseRate":0,"avgChangeRate":-0.176016},{"month":11,"riseRate":0.75,"avgChangeRate":0.166718},{"month":12,"riseRate":0.25,"avgChangeRate":-0.165944}],"exchange":"NASDAQ","name":"BriaCell Therapeutics Corp.","nameEN":"BriaCell Therapeutics Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BriaCell Therapeutics Corp.(BCTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BriaCell Therapeutics Corp.(BCTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BriaCell Therapeutics Corp.,BCTX,BriaCell Therapeutics Corp.股票,BriaCell Therapeutics Corp.股票老虎,BriaCell Therapeutics Corp.股票老虎国际,BriaCell Therapeutics Corp.行情,BriaCell Therapeutics Corp.股票行情,BriaCell Therapeutics Corp.股价,BriaCell Therapeutics Corp.股市,BriaCell Therapeutics Corp.股票价格,BriaCell Therapeutics Corp.股票交易,BriaCell Therapeutics Corp.股票购买,BriaCell Therapeutics Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BriaCell Therapeutics Corp.(BCTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BriaCell Therapeutics Corp.(BCTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}